Article
The EU Data Act’s Access-by-Design Deadline: What Life Sciences Companies Need To Know Before September 2026
The EU Data Act's September 2026 deadline introduces a new access-by-design requirement for connected medical devices and related services, but the practical impact may be more limited than manufacturers expect. This analysis examines what life sciences companies must do to comply with both the upcoming milestone and the broader set of obligations that have been in force since September 2025.
Arnold & Porter